Some 6-aza-5-substituted-2'-deoxyuridines show potent and selective inhibition of herpes simplex virus type 1 thymidine kinase. 1998

I Basnak, and M Sun, and T A Hamor, and F Focher, and A Verri, and S Spadari, and B Wroblowski, and P Herdewijn, and R T Walker
School of Chemistry, University of Birmingham, UK.

The synthesis and X-ray crystal structures of a series of 5-substituted-6-aza-2'-deoxyuridines is reported. These nucleoside analogues inhibit the phosphorylation of thymidine by HSV-1 TK but have no effect on the corresponding human enzyme. Detailed examination of one analogue proves it to be a competitive inhibitor of thymidine with a Ki of 0.34 microM and is a very poor substrate. The analogues are not substrates for the enzyme and also do not inhibit the degradation of thymidine by thymidine phosphorylase. Molecular modelling showed that the inhibitors fit well in the active site of HSV-1 TK, provided the conformation of the sugar moiety is the same for thymidine in the complex.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D009705 Nucleosides Purine or pyrimidine bases attached to a ribose or deoxyribose. (From King & Stansfield, A Dictionary of Genetics, 4th ed) Nucleoside,Nucleoside Analog,Nucleoside Analogs,Analog, Nucleoside,Analogs, Nucleoside
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D003857 Deoxyuridine 2'-Deoxyuridine. An antimetabolite that is converted to deoxyuridine triphosphate during DNA synthesis. Laboratory suppression of deoxyuridine is used to diagnose megaloblastic anemias due to vitamin B12 and folate deficiencies. (beta 1-(2-Deoxyribopyranosyl))thymidine
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006561 Herpes Simplex A group of acute infections caused by herpes simplex virus type 1 or type 2 that is characterized by the development of one or more small fluid-filled vesicles with a raised erythematous base on the skin or mucous membrane. It occurs as a primary infection or recurs due to a reactivation of a latent infection. (Dorland, 27th ed.) Herpes Simplex Virus Infection

Related Publications

I Basnak, and M Sun, and T A Hamor, and F Focher, and A Verri, and S Spadari, and B Wroblowski, and P Herdewijn, and R T Walker
May 1996, Antiviral research,
I Basnak, and M Sun, and T A Hamor, and F Focher, and A Verri, and S Spadari, and B Wroblowski, and P Herdewijn, and R T Walker
January 1979, Advances in ophthalmology = Fortschritte der Augenheilkunde = Progres en ophtalmologie,
I Basnak, and M Sun, and T A Hamor, and F Focher, and A Verri, and S Spadari, and B Wroblowski, and P Herdewijn, and R T Walker
November 1996, Journal of medicinal chemistry,
I Basnak, and M Sun, and T A Hamor, and F Focher, and A Verri, and S Spadari, and B Wroblowski, and P Herdewijn, and R T Walker
January 2004, Nucleosides, nucleotides & nucleic acids,
I Basnak, and M Sun, and T A Hamor, and F Focher, and A Verri, and S Spadari, and B Wroblowski, and P Herdewijn, and R T Walker
October 1979, The Journal of biological chemistry,
I Basnak, and M Sun, and T A Hamor, and F Focher, and A Verri, and S Spadari, and B Wroblowski, and P Herdewijn, and R T Walker
May 1986, Journal of medicinal chemistry,
I Basnak, and M Sun, and T A Hamor, and F Focher, and A Verri, and S Spadari, and B Wroblowski, and P Herdewijn, and R T Walker
December 1982, The Journal of general virology,
I Basnak, and M Sun, and T A Hamor, and F Focher, and A Verri, and S Spadari, and B Wroblowski, and P Herdewijn, and R T Walker
July 1974, Journal of virology,
I Basnak, and M Sun, and T A Hamor, and F Focher, and A Verri, and S Spadari, and B Wroblowski, and P Herdewijn, and R T Walker
July 2001, Bioorganic & medicinal chemistry letters,
I Basnak, and M Sun, and T A Hamor, and F Focher, and A Verri, and S Spadari, and B Wroblowski, and P Herdewijn, and R T Walker
June 2002, Journal of virology,
Copied contents to your clipboard!